In this blog for clinicians, researchers, people with depression and those supporting them, Andrew Moriarty (Academic GP), Nick Meader (Researcher), Emma Williams (Expert by experience) and Carolyn Chew-Graham (Professor of General Practice Research) look at the latest Cochrane evidence on predicting relapse of depression. Is predicting relapse possible, and likely to be useful to general practitioners (GPs) and patients?
Tag: Cochrane Common Mental Disorders Group
In this blog for patients and doctors, Dr Mark Horowitz, training psychiatrist and Clinical Research Fellow at University College London, looks at the latest Cochrane evidence on how to safely stop antidepressants and explores the implications for patients and doctors having to navigate this area so neglected by medical researchers. Mark’s personal experience of the difficulty in coming off antidepressants led to an interest in the little-understood field of stopping psychiatric medication, and the balance of harms and benefits.
In this blog for people with depression and their mental health practitioners, Emily Sanger, a Junior Doctor in York, looks at the latest Cochrane evidence from two reviews on Behavioural Activation Therapy and explores how well it works for depression in adults, with and without long-term physical conditions.
In this blog for World Mental Health Day 2019, Jessica Hendon, the Managing Editor of Cochrane Common Mental Disorders Group (CCMD), highlights the group's ongoing work to bring together the best evidence on suicide prevention and self-harm.
This blog looks at the at the problems with sex that vaginismus can cause, the poor evidence-base for treatments, and what needs to change.
Introducing Cochrane UK's special blog series #theproblemwithsex, which aims to lift the lid on sex and chronic health conditions